NasdaqGM - Nasdaq Real Time Price USD

KalVista Pharmaceuticals, Inc. (KALV)

11.34
-0.30
(-2.58%)
At close: May 14 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
172,968
131,993
95,086
81,310
57,923
Operating Income
-172,968
-131,993
-95,086
-81,310
-57,923
Net Non Operating Interest Income Expense
3,114
3,896
2,232
1,090
903
Other Income Expense
-1,766
1,453
-53
-2,119
10,776
Pretax Income
-171,620
-126,644
-92,907
-82,339
-46,244
Tax Provision
4,247
0
0
0
0
Net Income Common Stockholders
-175,867
-126,644
-92,907
-82,339
-46,244
Diluted NI Available to Com Stockholders
-175,867
-126,644
-92,907
-82,339
-46,244
Basic EPS
-3.77
-3.44
-3.33
-3.36
-2.42
Diluted EPS
-3.77
-3.44
-3.33
-3.36
-2.42
Basic Average Shares
47,252.46
36,786.58
27,890.85
24,473.09
19,094.44
Diluted Average Shares
47,252.46
36,786.58
27,890.85
24,473.09
19,094.44
Total Operating Income as Reported
-181,420
-140,445
-110,871
-96,613
-57,923
Total Expenses
172,968
131,993
95,086
81,310
57,923
Net Income from Continuing & Discontinued Operation
-175,867
-126,644
-92,907
-82,339
-46,244
Normalized Income
-176,338
-128,107
-92,858
-80,221
-47,091
Interest Income
5,956
3,896
2,232
1,090
903
Net Interest Income
3,114
3,896
2,232
1,090
903
EBIT
-174,127
-131,993
-95,086
-81,310
-57,923
EBITDA
-173,228
-131,177
-94,368
-80,746
-57,386
Reconciled Depreciation
899
816
718
564
537
Net Income from Continuing Operation Net Minority Interest
-175,867
-126,644
-92,907
-82,339
-46,244
Total Unusual Items Excluding Goodwill
785
1,463
-49
-2,118
847
Total Unusual Items
785
1,463
-49
-2,118
847
Normalized EBITDA
-174,013
-132,640
-94,319
-78,628
-58,233
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
314
0
0
0
0
4/30/2021 - 4/9/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PHVS Pharvaris N.V.
16.07
-0.25%
 
URGN UroGen Pharma Ltd.
9.87
-2.66%
 
ABEO Abeona Therapeutics Inc.
5.39
-4.26%
 
UNCY Unicycive Therapeutics, Inc.
0.5583
-7.83%
 
TARS Tarsus Pharmaceuticals, Inc.
42.90
+3.47%
 
ATXS Astria Therapeutics, Inc.
3.9700
+1.79%
 
TRML Tourmaline Bio, Inc.
15.50
-0.26%
 
NUVB Nuvation Bio Inc.
2.1700
-0.91%
 
EWTX Edgewise Therapeutics, Inc.
14.55
-2.28%
 
KURA Kura Oncology, Inc.
5.73
-1.21%